During the past decade, Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik" in a lesser frequency.

Most popular intervention types in "Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Crizotinib" (1 trials), "Dummy infusion" (1 trials), "Lorlatinib" (1 trials) and "ThermoDox" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".